We are a leading supplier of high-grade Active Pharmaceutical Ingredients (API), specialty chemicals, FMOC amino acids, and pharmaceutical intermediates. Our comprehensive product portfolio serves pharmaceutical manufacturers, research institutions, and biotechnology companies worldwide with ISO-certified quality standards.
Our FMOC (Fluorenylmethyloxycarbonyl) amino acids are essential building blocks for solid-phase peptide synthesis (SPPS). These protected amino acids ensure high purity and efficiency in peptide manufacturing processes.
| Sr No | FMOC Amino Acids | CAS Number | Application |
|---|---|---|---|
| 1 | Fmoc-OSu; N-(9-Fluorenylmethoxycarbonylo xy) succinimide | 82911-69-1 | Peptide synthesis, Protein chemistry |
| 2 | Boc-Anhydride | 24424-99-5 | Peptide synthesis, Amino acid protection |
| 3 | Fmoc-Glycine | 29022-11-5 | Peptide synthesis, Pharmaceutical intermediates |
| 4 | Fmoc-L-Alanine | 207291-76-7 | Peptide synthesis, Drug development |
| 5 | Fmoc-L-Valine | 68858-20-8 | Peptide synthesis, Bioactive compounds |
| 6 | Fmoc-L-Leucine | 35661-60-0 | Peptide synthesis, Pharmaceutical research |
| 7 | Fmoc-L-Isoleucine | 71989-23-6 | Peptide synthesis, Protein engineering |
| 8 | Fmoc-L-Proline | 71989-31-6 | Peptide synthesis, Structural studies |
| 9 | Fmoc-L-Methionine | 71989-28-1 | Peptide synthesis, Protein modification |
| 10 | Fmoc-L-Phenylalanine | 35661-40-6 | Peptide synthesis, Aromatic peptides |
| 11 | Fmoc-L-Phenylglycine | 102410-65-1 | Peptide synthesis, Non-natural amino acids |
| 12 | Fmoc-L-Cys(Trt)-OH | 103213-32-7 | Peptide synthesis, Disulfide bond formation |
| 13 | Fmoc-L-Lys(BOC)-OH | 71989-26-9 | Peptide synthesis, Basic amino acids |
| 14 | Fmoc-L-Arg(Pbf)-OH | 154445-77-9 | Peptide synthesis, Guanidino protection |
| 15 | Fmoc-L-Ser(tBu)-OH | 71989-33-8 | Peptide synthesis, Hydroxyl protection |
| 16 | Fmoc-L-Thr(tBu)-OH | 71989-35-0 | Peptide synthesis, Secondary alcohol protection |
| 17 | Fmoc-L-Tyr(tBu)-OH | 71989-38-3 | Peptide synthesis, Phenolic protection |
| 18 | Fmoc-L-Asp(OtBu)-OH | 71989-14-5 | Peptide synthesis, Carboxylic acid protection |
| 19 | Fmoc-L-Glu(OtBu)-OH | 71989-18-9 | Peptide synthesis, Acidic amino acids |
| 20 | Fmoc-L-Gln(Trt)-OH | 132327-80-1 | Peptide synthesis, Amide protection |
| 21 | Fmoc-L-Asn(Trt)-OH | 132388-59-1 | Peptide synthesis, Asparagine derivatives |
| 22 | Fmoc-L-Trp(Boc)-OH | 143824-78-6 | Peptide synthesis, Indole protection |
| 23 | Fmoc-L-His(Trt)-OH | 109425-51-6 | Peptide synthesis, Imidazole protection |
| 24 | Boc-Histidine | - | Peptide synthesis, Alternative protection |
| 25 | Boc-Gln-OH | - | Peptide synthesis, BOC strategy |
| 26 | Boc-Gly-OH | - | Peptide synthesis, BOC protection |
| 27 | Boc-L-Alanine | - | Peptide synthesis, BOC derivatives |
| 28 | Boc-L-Valine | - | Peptide synthesis, Branched amino acids |
| 29 | Boc-L-Leucine | - | Peptide synthesis, Hydrophobic amino acids |
| 30 | Boc-L-Arginine HCl monohydrate | - | Peptide synthesis, Basic amino acid salts |
| 31 | Boc-L-Phenylalaninol | - | Peptide synthesis, Alcohol derivatives |
| 32 | Boc-L-Alaninol | - | Peptide synthesis, Reduced amino acids |
| 33 | Boc-L-Prolinol | - | Peptide synthesis, Cyclic amino alcohols |
High-purity bile acids for binding studies, membrane research, and pharmaceutical applications. Essential for lipid metabolism studies and drug formulation research.
| Sr No | Bile Acids | CAS Number | Application |
|---|---|---|---|
| 1 | Sodium Glycocholate hydrate (GC) | 338950-81-5 | Binding studies, Membrane research |
| 2 | Sodium Glycochenodeoxycholate 97% (GCDC) | 16564-43-5 | Binding studies, Lipid solubilization |
| 3 | Taurodeoxycholic acid sodium salt hydrate (TDC) | 1180-95-6 | Binding studies, Drug formulation |
Premium coupling reagents for efficient amide bond formation in peptide and protein synthesis. Our coupling agents ensure high yields and minimal side reactions.
| Sr No | Coupling Agents | CAS Number | Application |
|---|---|---|---|
| 1 | HATU | 148893-10-1 | Peptide Synthesis, Amide bond formation |
| 2 | HOAt | 39968-33-7 | Peptide Synthesis, Coupling additive |
| 3 | HOBt Monohydrate | 123333-53-9 | Peptide Synthesis, Racemization suppression |
| 4 | EDC HCl | 25952-53-8 | Peptide Synthesis, Carbodiimide coupling |
| 5 | DIC | 693-13-0 | Peptide Synthesis, Solution phase coupling |
| 6 | HBTU | 94790-37-1 | Peptide Synthesis, Uronium coupling |
| 7 | TBTU | 125700-67-6 | Peptide Synthesis, Alternative uronium salt |
| 8 | BOP | 56602-33-6 | Peptide Synthesis, Phosphonium coupling |
| 9 | PyBOP | 128625-52-5 | Peptide Synthesis, Improved BOP reagent |
| 10 | CDMT | 3140-73-6 | Peptide Synthesis, Triazine coupling |
| 11 | DMTMM | 3945-69-5 | Peptide Synthesis, Morpholinium coupling |
| 12 | TCFH | 94790-35-9; 207915-99-9 | Peptide Synthesis, Chloroformamidinium salt |
| 13 | PyCLOP | 133894-48-1 | Peptide Synthesis, Phosphonium derivative |
| 14 | OXIMA | 3849-21-6 | Peptide Synthesis, Oxime coupling |
| 15 | TSTU | 105832-38-0 | Peptide Synthesis, Tetramethyl uronium |
| 16 | HCTU | 330645-87-9 | Peptide Synthesis, Cyclohexyl uronium |
| 17 | TATU | 873798-09-5 | Peptide Synthesis, Advanced coupling reagent |
High-quality solid-phase synthesis resins for peptide manufacturing. Our resins provide excellent loading capacity and stability for automated peptide synthesis.
| Sr No | Resins for Peptide Synthesis | CAS Number | Application |
|---|---|---|---|
| 1 | Wang Resin | - | Peptide Synthesis, C-terminal acids |
| 2 | CTC Resin | - | Peptide Synthesis, Chlorotrityl support |
| 3 | Rink Amide Resin | - | Peptide Synthesis, C-terminal amides |
| 4 | Indole Methyl Resin | - | Peptide Synthesis, Special applications |
| 5 | Indole Methyl Resin | - | Peptide Synthesis, Alternative support |
Our comprehensive range of Active Pharmaceutical Ingredients meets the highest quality standards including IP/USP/BP/EP/IH specifications. We supply APIs for cardiovascular, neurological, oncology, and other therapeutic areas.
| Sr No | Active Pharmaceutical Ingredient | Quality Grade | CAS Number | Therapeutic Application |
|---|---|---|---|---|
| 1 | PREGABALIN - Anticonvulsant API | IP/USP/BP/EP/IH | 148553-50-8 | Anticonvulsant and neuropathic pain treatment |
| 2 | METOPROLOL SUCCINATE - Beta Blocker API | IP/USP/BP/EP | 98418-47-4 | Cardiovascular diseases, hypertension treatment |
| 3 | METOPROLOL TARTRATE - Cardiovascular API | IP/USP/BP/EP | 56392-17-7 | Heart disease, blood pressure management |
| 4 | LEVOSULPRIDE - Antipsychotic API | IH | 23672-07-3 | Psychiatric conditions, depression, schizophrenia treatment |
| 5 | AMISULPRIDE - Antipsychotic API | IP/BP/EP | 71675-85-9 | Acute and chronic schizophrenic disorders |
| 6 | SULPRIDE - Psychiatric API | IP/BP | 15676-16-1 | Acute and chronic schizophrenia treatment |
| 7 | ITOPRIDE HYDROCHLORIDE - Gastroprokinetic API | IH/IP | 122892-31-3 | Functional dyspepsia, nausea and vomiting treatment |
| 8 | BENIDIPINE - Calcium Channel Blocker API | IH/JP | 91599-74-5 | Hypertension and angina treatment |
| 9 | CLINIDIPINE - Antihypertensive API | IH/IP/JP | 132203-70-4 | Cardiovascular conditions, hypertension management |
| 10 | LETROZOLE - Aromatase Inhibitor API | IP/USP | 112809-51-5 | Breast cancer treatment and prevention |
| 11 | L-CARNITINE-L TARTRATE - Nutritional API | IH | 36687-82-8 | Nutritional supplement for diabetes and cardiac health |
| 12 | PROPYL GALLATE - Antioxidant API | IP/BP/USP | 121-79-9 | Antioxidant, fat and oil preservation |
| 13 | IRON(III) HYDROXIDE POLYMALTOSE COMPLEX | IH | 53858-86-9 | Iron deficiency anemia treatment |
| 14 | LEVOCLOPERASTINE FENDIZOAE - Antitussive API | IH | 220329-19-1 | Dry cough treatment |
| 15 | CLOPERASTINE FENDIZOATE - Cough Suppressant API | IH | 85187-37-7 | Cough treatment after underlying cause exclusion |
| 16 | OXYTETRACYCLINE DIHYDRATE - Antibiotic API | BP/IP | 6153-64-6 | Respiratory, urinary tract, and skin infections |
| 17 | RACECADOTRIL - Antidiarrheal API | IP/BP | 81110-79-8 | Diarrhea treatment |
| 18 | POSACONAZOLE - Antifungal API | IH/IP | 171228-49-2 | Serious fungal infection prevention |
| 19 | TORSEMIDE - Diuretic API | IH | 56211-40-6 | Fluid retention, edema, heart failure treatment |
| 20 | TRAZODONE - Antidepressant API | IH | 19794-93-5 | Depression, anxiety treatment |
| 21 | CITICOLINE - Nootropic API | IH | 987-78-0 | Brain performance, memory enhancement, stroke treatment |
| 22 | Leuprolide Acetate USP - Hormone Therapy API | USP | 74381-53-6 | GnRH agonist and antineoplastic agent |
| 23 | Octreotide Acetate USP/EP - Somatostatin Analog | USP/EP | 79517-01-4 | Acromegaly and carcinoid tumor treatment |
| 24 | Ganirelix Acetate - GnRH Antagonist API | IH | 129311-55-3 | GnRH antagonist for reproductive medicine |
| 25 | Triptorelin Pamoate/Acetate - Hormone API | IH | 140194-24-7 | GnRH agonist and antineoplastic agent |
| 26 | Cetrorelix Acetate - Fertility Treatment API | IH | 145672-81-7 | GnRH antagonist and antineoplastic agent |
| 27 | Degarelix Acetate - Prostate Cancer API | IH | 93401-19-0 | GnRH antagonist and antineoplastic agent |
| 28 | Goserelin BP - Cancer Treatment API | BP | 145781-92-6 | GnRH antagonist and antineoplastic agent |
| 29 | Desmopressin USP/EP/IP - Hormone API | USP/EP/IP | 62288-83-9 | Anti-diuretic hormone therapy |
| 30 | Exenatide USP - Diabetes API | USP | 14732-76-5 | Antidiabetic, GLP1 receptor agonist |
| 31 | Terlipressin Acetate EP - Vasoconstrictor API | EP | 914453-96-6 | Kidney function improvement in hepatorenal syndrome |
| 32 | Vasopressin USP/IP - Hormone API | USP/IP | 113-79-1 | Antidiuretic hormone therapy |
| 33 | Teriparatide USP/EP/IP - Bone Health API | USP/EP/IP | 52232-67-4 | Osteoporosis treatment in postmenopausal women |
| 34 | Buserelin BP/IP - Prostate Cancer API | BP/IP | 57982-77-1 | Prostate cancer treatment |
| 35 | Bivalirudin - Anticoagulant API | IH | 128270-60-0 | Anti-coagulant/Anti-thrombin therapy |
| 36 | Glatiramer Acetate - Multiple Sclerosis API | IH | 14745-92-9 | Multiple sclerosis treatment |
| 37 | Atosiban Acetate IP - Labor Suppressant API | IH | 914453-95-5 | Labor repressant therapy |
| 38 | Carbetocin - Obstetric API | IH | 37025-55-1 | Postpartum bleeding treatment |
| 39 | Micafungin Sodium USP - Antifungal API | USP | 208538-73-2 | Antifungal therapy |
| 40 | Anidulafungin Fructose - Antifungal API | IH | 166663-25-8 | Antifungal treatment |
| 41 | Rezafungin Acetate - Advanced Antifungal API | IH | 1631754-41-0 | Anti-fungal therapy |
| 42 | Omadacycline - Antibiotic API | IH | 389139-89-3 | Broad-spectrum antibiotic |
| 43 | Ibrexafungerp Citrate - Novel Antifungal API | IH | 1207753-03-4 | Advanced antifungal treatment |
High-quality pharmaceutical granules and pellets for controlled release and improved bioavailability. Our granulation technology ensures uniform particle size and optimal drug delivery.
| Sr No | Pharmaceutical Granules | Quality Grade | CAS Number | Therapeutic Application |
|---|---|---|---|---|
| 1 | ALPHA LIPOIC ACID 50/80/90% W/W GRANULES & PELLETS | IH/USP | 1077-28-7 | Diabetic neuropathy, nerve pain treatment |
Essential pharmaceutical intermediates for API synthesis and drug development. Our intermediates support the manufacture of various therapeutic compounds with consistent quality and purity.
| Sr No | Pharmaceutical Intermediates | CAS Number | Target API / Application |
|---|---|---|---|
| 1 | 3-ISOBUTYLGLUTARIC ACID METHYL ESTER | 181289-11-2 | PREGABALIN synthesis |
| 2 | N,N-DIMETHYL AMINO ETHYL CHLORIDE HCL | 4584-46-7 | AMIODARONE, DILTIAZEM synthesis |
| 3 | N,N-DIETHYL AMINO ETHYL CHLORIDE HCL | 869-24-9 | AMIODARONE, DILTIAZEM synthesis |
| 4 | FENDIZOIC ACID | 84627-04-3 | CLOPERASTINE synthesis |
| 5 | 3-CARBAMOYMETHYL-5-METHYLHEXANOIC ACID | 181289-15-6 | PREGABALIN synthesis |
| 6 | (R)-(-)-O-ACETYLMANDELIC ACID | 51019-43-3 | Chiral resolving agent |
| 7 | 4-HYDROXY BENZOPHENONE | 1137-42-4 | CLOMIFENE synthesis |
| 8 | ETHYL 2-(3-FORMYL-4-HYDROXYPHENYL)-4-METHYL-1,3 | 161798-01-2 | FEBUXOSTAT synthesis |
| 9 | SEMICARBAZIDE HYDROCHLORIDE | 563-41-7 | TRAZODONE synthesis |
| 10 | METHANESULFONIC ACID 2-[2-(2,2,2-TRIFLUOROETHOXY)PHENOXY]ETHYL ESTER | 160969-03-9 | SILODOSIN synthesis |
| 11 | 3-AMINO-2-CROTONIC ACID CINNAMYL ESTER | 103909-86-0 | CILNIDIPINE synthesis |
| 12 | 2-METHOXYETHYL 2-3-NITROBENZYLIDENE)-3-OXOBUTANOATE | 39562-22-6 | CILNIDIPINE synthesis |
| 13 | 5-CHLORO SALICYLIC ACID | 321-14-2 | NICLOSAMIDE synthesis |
| 14 | (PHENYLMETHYL)-2-PROPENOIC ACID | 5669-19-2 | RACECADOTRIL synthesis |
| 15 | BENZYL GLYCINATE P-TOLUENESULFONATE | 1738-76-7 | RACECADOTRIL synthesis |
| 16 | 4 Amino Pyridine | 504-24-5 | TORSEMIDE synthesis |
| 17 | 2,4-Amino-3-Pyridine Sulphonic Acid | 29452-57-1 | TORSEMIDE synthesis |
| 18 | 3,4-Hydroxy-3-Pyridine Sulphonic Acid | 51498-37-4 | TORSEMIDE synthesis |
| 19 | 4,4-(3 Methyl Phenyl) Amino-3-Pyridine Sulfonamide | 72811-73-5 | TORSEMIDE synthesis |
| 20 | [1,2,4]Triazolo [4,3-A]Pyridine 3(2h) One | 6969-71-7 | TRAZODONE synthesis |
| 21 | [1,2,4]Triazolo [4,3-A]Pyridine3(2h) One - Sodium Salt | 6969-71-7 | TRAZODONE synthesis |
| 22 | 1-(3-Chloro Phenyl)-4-(3-Chloro Propyl) Piperazine HCl | 65369-76-8 | TRAZODONE synthesis |
| 23 | Para Hydroxy Coumarin Or 4-Hydroxy Coumarin | 1076-38-6 | WARFARIN synthesis |
| 24 | Calcium Phosphoryl Choline Chloride | 72556-74-2 | CITICOLINE synthesis |
| 25 | 3-Amino-1H Pyrazole-4-Carboxamide | 5334-31-6 | ALLOPURINOL synthesis |
| 26 | 2 Chloro – 5 Nitro Benzoic Acid | 2516-96-3 | MESALAMINE synthesis |
| 27 | 2,3-DIHYDROBENZO [B] [1,4] DIOXINE-2-CARBOXYLIC ACID | 3663-80-7 | DOXAZOSIN synthesis |
| 28 | 4 – Chloro – 2 Amino Benzo Nitrile | 38487-86-4 | QUINAZOLINE derivatives |
Comprehensive range of pharmaceutical-grade vitamins, iron complexes, and mineral supplements. Our products support nutritional therapy and supplement manufacturing with superior bioavailability.
| Sr No | Nutritional Products | Specification |
|---|---|---|
| 1 | Vitamin B2 Gelatin Triturate 1% | Pharmaceutical grade riboflavin |
| 2 | Vitamin B2 Gelatin Triturate 0.1% | Low concentration riboflavin |
| 3 | Cyanocobalamin Triturate 0.1%, 0.5%, 1.0% with mannitol | Vitamin B12 formulations |
| 4 | Vitamin D3 Stabilized 0.02 MIU/gm, 0.1MIU/gm, 0.5MIU/gm, 0.850 MIU/gm | Cholecalciferol concentrates |
| 5 | Cholecalciferol concentrate powder from IP | Vitamin D3 pharmaceutical grade |
| 6 | Mecobalamin triturate 5% in Mannitol, 5% triturate in Gelatin | Methylcobalamin formulations |
| 7 | Alpha Lipoic acid 80% | Antioxidant supplement |
| 8 | Ferrous Ascorbate | Iron-vitamin C complex |
| 9 | Ferrous Glycinate | Chelated iron supplement |
| 10 | Ferrous Glycine sulphate | Iron amino acid complex |
| 11 | Carbonyl Iron USP | High bioavailability iron |
| 12 | Ferbonyl powder (Carbonyl Iron) | Iron deficiency treatment |
| 13 | Ferrous ascorbate IP | Indian Pharmacopoeia grade |
| 14 | Iron Peponate | Organic iron complex |
| 15 | 5% Iron sucrose complex (Pyrogen free) | Injectable iron preparation |
| 16 | Iron Dextran Complex (pyrogen free) | Parenteral iron therapy |
| 17 | Iron Sorbitol Citric Acid Complex (Pyrogen Free) | Injectable iron formulation |
| 18 | Calcium Ascorbate B.P. | Calcium-vitamin C complex |
| 19 | Zinc Ascorbate | Zinc-vitamin C combination |
| 20 | Zinc Bisglycinate | Chelated zinc supplement |
Comprehensive collection of pharmaceutical impurity standards for quality control and analytical testing. Our reference standards support regulatory compliance and method validation for API testing.
High-quality pharmaceutical excipients for tablet and capsule formulation. Our excipients ensure optimal drug stability, bioavailability, and manufacturing efficiency.
| Sr No | Pharmaceutical Excipients | CAS Number | Function |
|---|---|---|---|
| 1 | ZINC STEARATE | 557-05-1 | Lubricant, anti-adherent agent |
| 2 | CALCIUM STEARATE | 1592-23-0 | Lubricant, release agent |
| 3 | MAGNESIUM STEARATE | 557-04-0 | Lubricant, anti-adherent agent |
Professional-grade biocidal disinfectants for pharmaceutical manufacturing environments. Our antimicrobial solutions ensure compliance with GMP standards and microbial control.
| Sr No | Biocidal Surface Disinfectants | CAS Number | Application |
|---|---|---|---|
| 1 | 1,6-DIHYDROXY 2,5-DIOXAHEXANE | 3586-55-8 | Pharmaceutical surface disinfection |
| 2 | GLUTARALDEHYDE 50% | 111-30-8 | High-level disinfection and sterilization |
| 3 | ALKYL UREA DERIVATIVES | - | Broad-spectrum antimicrobial activity |
| 4 | BENZALKONIUM CHLORIDE (50/80/90%) | 8001-54-5 | Quaternary ammonium disinfectant |
Specialized chemicals for agricultural applications and crop protection. Our agricultural chemicals support sustainable farming practices and crop yield optimization.
| Sr No | Agricultural Chemical Application | CAS Number | Category |
|---|---|---|---|
| 1 | 5-CHLORO SALICYLIC ACID METHYL ESTER | 4068-78-4 | Agricultural chemicals & pharmaceutical intermediates |
We are expanding our product portfolio to include laboratory consumables and equipment. Stay tuned for updates on our comprehensive range of laboratory supplies.
All our APIs and pharmaceutical ingredients meet international quality standards including IP, USP, BP, EP, and IH specifications.
Reliable worldwide distribution network ensuring timely delivery of pharmaceutical raw materials and APIs.
Technical expertise and analytical support for pharmaceutical development and manufacturing processes.
27/Broadway Business Hub, Opp. to Bharat Petroleum Bhayali, Vadodara-391 410, Gujarat. India.
+91 94263 32930
yuvaraj@shriharipharmachem.com
© Shri Hari Pharmachem. All Rights Reserved. Develop by NaynitTech